| 000 | 01466 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516165720.0 | ||
| 264 | 0 | _c20140714 | |
| 008 | 201407s 0 0 eng d | ||
| 022 | _a1526-4610 | ||
| 024 | 7 |
_a10.1111/head.12167 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aObaidi, Mohammad | |
| 245 | 0 | 0 |
_aImproved pharmacokinetics of sumatriptan with Breath Powered™ nasal delivery of sumatriptan powder. _h[electronic resource] |
| 260 |
_bHeadache _cSep 2013 |
||
| 300 |
_a1323-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aDry Powder Inhalers _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNasal Cavity _xdrug effects |
| 650 | 0 | 4 | _aRespiration |
| 650 | 0 | 4 |
_aSerotonin 5-HT1 Receptor Agonists _xadministration & dosage |
| 650 | 0 | 4 |
_aSumatriptan _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aOffman, Elliot | |
| 700 | 1 | _aMessina, John | |
| 700 | 1 | _aCarothers, Jennifer | |
| 700 | 1 | _aDjupesland, Per G | |
| 700 | 1 | _aMahmoud, Ramy A | |
| 773 | 0 |
_tHeadache _gvol. 53 _gno. 8 _gp. 1323-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/head.12167 _zAvailable from publisher's website |
| 999 |
_c23047753 _d23047753 |
||